Are SARS‐CoV‐2 IgA antibodies in paediatric patients with chilblain‐like lesions indicative of COVID‐19 asymptomatic or paucisymptomatic infection?
A Diociaiuti, S Giancristoforo, S Terreri, M Corbeddu, C Concato, M Ciofi Degli Atti, G Zambruno, R Carsetti, M El Hachem
Journal of the European Academy of Dermatology and Venereology, doi:10.1111/jdv.16934
was positive in eight cases, borderline in two, and negative in three, including the COVID-19 patient. Overall, serology for S1-specific IgA and IgG in the 30 patients shows that 16 (53.3%) were positive for IgA, whereas IgG was detectable in five (16.6%; Fig. 1f ). We have recently reported that high levels of IgG and IgA can be detected in adult patients with severe COVID-19, while IgA, and to a lower extent IgG, is increased in asymptomatic individuals. 6 As IgA is the most abundant antibody at mucosal sites, a strong local protection may prevent viral spread and damage to the respiratory tract, explaining the lack of symptoms. The ELISA used for the detection of anti-S1 IgG and IgA has been demonstrated to be specific and sensitive. 7, 8 Of note, antibodies against S1 are often neutralizing 9 and may prevent severe disease and further immune responses. 6 Our findings indicate that, similar to asymptomatic adults, paediatric patients would respond to SARS-CoV-2 producing more IgA than IgG. On the other hand, a single patient had detectable IgG against SARS-CoV-2 nucleoprotein. Anti-nucleoprotein IgG is present in the great majority of hospitalized adult patients, but only in one-third of paucisymptomatic individuals, suggesting that disease severity influences the specificity of the antibodies produced. 10 In conclusion, the detection of S1-specific IgA in paediatric patients with chilblain-like lesions strongly points to a previous, mostly asymptomatic SARS-CoV-2 infection with inflammatory sequelae.
Conflicts of interest None to be reported for all authors. A. Diociaiuti, 1,*, † S. Giancristoforo, 1, † S. Terreri, 2 M. Corbeddu, 1 C. Concato, 3 M. Ciofi Degli Atti, 4 G. Zambruno, 5 R. Carsetti, 6, † M. El Hachem 1, †
Conflicts of interest None declared.
References
Andina, Noguera-Morel, Bascuas-Arribas, Chilblains in children in the setting of COVID-19 pandemic, Pediatr Dermatol
Beavis, Matushek, Abeleda, Evaluation of the EUROIM-MUN Anti-SARS-CoV-2 ELISA assay for detection of IgA and IgG antibodies, J Clin Virol
Carsetti, Zaffina, Mortari, Spectrum of innate and adaptive immune response to SARS CoV 2 infection across asymptomatic, mild and severe cases; a longitudinal cohort study, medRxiv,
doi:10.1101/2020.06.22.20137141Caturegli, Materi, Howard, Caturegli, Clinical validity of serum antibodies to SARS-CoV-2: a case-control study, Ann Intern Med
Cleach, Dousset, Assier, Most chilblains observed during the COVID-19 outbreak occur in patients who are negative for COVID-19 on PCR and serology testing, Br J Dermatol
El Hachem, Diociaiuti, Concato, A clinical, histopathological and laboratory study of 19 consecutive Italian paediatric patients with chilblain-like lesions: lights and shadows on the relationship with COVID-19 infection, J Eur Acad Dermatol Venereol
Freeman, Mcmahon, Lipoff, Pernio-like skin lesions associated with COVID-19: a case series of 318 patients from 8 countries, J Am Acad Dermatol
Gebhard, Regitz-Zagrosek, Neuhauser, Morgan, Klein, Impact of sex and gender on COVID-19 outcomes in Europe, Biol Sex Differ
Ghazizadeh, Majd, Richter, Androgen regulates SARS-CoV-2 receptor levels and is associated with severe COVID-19 symptoms in men, bioRxiv,
doi:10.1101/2020.05.12.091082Grzelak, Temmam, Planchais, SARS-CoV-2 serological analysis of COVID-19 hospitalized patients, pauci-symptomatic individuals and blood donors, medRxiv,
doi:10.1101/2020.04.21.20068858Montopoli, Zumerle, Vettor, Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a populationbased study (N = 4532), Ann Oncol
Salgado, Handler, Schwartz, Shedding light on onychomadesis, Cutis
Seydoux, Homad, Maccamy, Analysis of a SARS-CoV-2-infected individual reveals development of potent neutralizing antibodies with limited somatic mutation, Immunity
Wadman, Sex hormones signal why virus hits men harder, Science
Wambier, Goren, Vaño-Galv An, Androgen sensitivity gateway to COVID-19 disease severity, Drug Dev Res
Wambier, Vaño-Galv An, Mccoy, Androgenetic alopecia present in the majority of hospitalized COVID-19 patients -the "Gabrin sign, J Am Acad Dermatol
{ 'indexed': {'date-parts': [[2024, 4, 3]], 'date-time': '2024-04-03T14:41:29Z', 'timestamp': 1712155289658},
'reference-count': 6,
'publisher': 'Wiley',
'issue': '1',
'license': [ { 'start': { 'date-parts': [[2020, 10, 21]],
'date-time': '2020-10-21T00:00:00Z',
'timestamp': 1603238400000},
'content-version': 'vor',
'delay-in-days': 0,
'URL': 'http://onlinelibrary.wiley.com/termsAndConditions#vor'}],
'content-domain': {'domain': ['onlinelibrary.wiley.com'], 'crossmark-restriction': True},
'published-print': {'date-parts': [[2021, 1]]},
'DOI': '10.1111/jdv.16953',
'type': 'journal-article',
'created': {'date-parts': [[2020, 9, 26]], 'date-time': '2020-09-26T00:00:25Z', 'timestamp': 1601078425000},
'update-policy': 'http://dx.doi.org/10.1002/crossmark_policy',
'source': 'Crossref',
'is-referenced-by-count': 43,
'title': 'Anti‐androgens may protect against severe COVID‐19 outcomes: results from a prospective cohort '
'study of 77 hospitalized men',
'prefix': '10.1111',
'volume': '35',
'author': [ { 'ORCID': 'http://orcid.org/0000-0002-8190-2289',
'authenticated-orcid': False,
'given': 'A.',
'family': 'Goren',
'sequence': 'first',
'affiliation': [{'name': 'Applied Biology, Inc. Irvine CA USA'}]},
{ 'ORCID': 'http://orcid.org/0000-0002-4636-4489',
'authenticated-orcid': False,
'given': 'C.G.',
'family': 'Wambier',
'sequence': 'additional',
'affiliation': [ { 'name': 'Department of Dermatology Alpert Medical School of Brown '
'University Providence RI USA'}]},
{ 'given': 'S.',
'family': 'Herrera',
'sequence': 'additional',
'affiliation': [{'name': 'Infectious Diseases Unit Ramón y Cajal Hospital Madrid Spain'}]},
{ 'ORCID': 'http://orcid.org/0000-0003-1577-9910',
'authenticated-orcid': False,
'given': 'J.',
'family': 'McCoy',
'sequence': 'additional',
'affiliation': [{'name': 'Applied Biology, Inc. Irvine CA USA'}]},
{ 'ORCID': 'http://orcid.org/0000-0003-2773-7494',
'authenticated-orcid': False,
'given': 'S.',
'family': 'Vaño‐Galván',
'sequence': 'additional',
'affiliation': [{'name': 'Dermatology Department Ramón y Cajal Hospital Madrid Spain'}]},
{ 'given': 'F.',
'family': 'Gioia',
'sequence': 'additional',
'affiliation': [{'name': 'Infectious Diseases Unit Ramón y Cajal Hospital Madrid Spain'}]},
{ 'given': 'B.',
'family': 'Comeche',
'sequence': 'additional',
'affiliation': [{'name': 'Infectious Diseases Unit Ramón y Cajal Hospital Madrid Spain'}]},
{ 'given': 'R.',
'family': 'Ron',
'sequence': 'additional',
'affiliation': [{'name': 'Infectious Diseases Unit Ramón y Cajal Hospital Madrid Spain'}]},
{ 'given': 'S.',
'family': 'Serrano‐Villar',
'sequence': 'additional',
'affiliation': [{'name': 'Infectious Diseases Unit Ramón y Cajal Hospital Madrid Spain'}]},
{ 'ORCID': 'http://orcid.org/0000-0002-1561-414X',
'authenticated-orcid': False,
'given': 'P.M.',
'family': 'Ramos',
'sequence': 'additional',
'affiliation': [ { 'name': 'Department of Dermatology São Paulo State University Botucatu '
'Brazil'}]},
{ 'given': 'F.A.',
'family': 'Cadegiani',
'sequence': 'additional',
'affiliation': [ { 'name': 'Department of Clinical Endocrinology Federal University of São '
'Paulo Medical School Sao Paulo Brazil'}]},
{ 'given': 'M.',
'family': 'Kovacevic',
'sequence': 'additional',
'affiliation': [ { 'name': 'Department of Dermatology and Venereology Hospital Sestre '
'Milosrdnice Zagreb Croatia'}]},
{ 'given': 'A.',
'family': 'Tosti',
'sequence': 'additional',
'affiliation': [ { 'name': 'Department of Dermatology and Cutaneous Surgery Miller School of '
'Medicine University of Miami Miami FL USA'}]},
{ 'given': 'J.',
'family': 'Shapiro',
'sequence': 'additional',
'affiliation': [ { 'name': 'Ronald O. Perelman Department of Dermatology at the New York '
'University School of Medicine New York NY USA'}]},
{ 'given': 'R.',
'family': 'Sinclair',
'sequence': 'additional',
'affiliation': [{'name': 'Sinclair Dermatology Melbourne VIC Australia'}]}],
'member': '311',
'published-online': {'date-parts': [[2020, 10, 21]]},
'reference': [ { 'key': 'e_1_2_4_2_1',
'doi-asserted-by': 'publisher',
'DOI': '10.1126/science.368.6495.1038'},
{'key': 'e_1_2_4_3_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1186/s13293-020-00304-9'},
{'key': 'e_1_2_4_4_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1002/ddr.21688'},
{'key': 'e_1_2_4_5_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.jaad.2020.05.079'},
{ 'key': 'e_1_2_4_6_1',
'doi-asserted-by': 'publisher',
'DOI': '10.1016/j.annonc.2020.04.479'},
{ 'key': 'e_1_2_4_7_1',
'article-title': 'Androgen regulates SARS‐CoV‐2 receptor levels and is associated with '
'severe COVID‐19 symptoms in men',
'author': 'Ghazizadeh Z',
'year': '2020',
'journal-title': 'bioRxiv'}],
'container-title': 'Journal of the European Academy of Dermatology and Venereology',
'original-title': [],
'language': 'en',
'link': [ { 'URL': 'https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.16953',
'content-type': 'application/pdf',
'content-version': 'vor',
'intended-application': 'text-mining'},
{ 'URL': 'https://onlinelibrary.wiley.com/doi/full-xml/10.1111/jdv.16953',
'content-type': 'application/xml',
'content-version': 'vor',
'intended-application': 'text-mining'},
{ 'URL': 'https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.16953',
'content-type': 'unspecified',
'content-version': 'vor',
'intended-application': 'similarity-checking'}],
'deposited': { 'date-parts': [[2023, 9, 3]],
'date-time': '2023-09-03T18:20:00Z',
'timestamp': 1693765200000},
'score': 1,
'resource': {'primary': {'URL': 'https://onlinelibrary.wiley.com/doi/10.1111/jdv.16953'}},
'subtitle': [],
'short-title': [],
'issued': {'date-parts': [[2020, 10, 21]]},
'references-count': 6,
'journal-issue': {'issue': '1', 'published-print': {'date-parts': [[2021, 1]]}},
'alternative-id': ['10.1111/jdv.16953'],
'URL': 'http://dx.doi.org/10.1111/jdv.16953',
'relation': { 'has-review': [ { 'id-type': 'doi',
'id': '10.3410/f.738737953.793579347',
'asserted-by': 'object'}]},
'ISSN': ['0926-9959', '1468-3083'],
'subject': ['Infectious Diseases', 'Dermatology'],
'container-title-short': 'Acad Dermatol Venereol',
'published': {'date-parts': [[2020, 10, 21]]},
'assertion': [ { 'value': '2020-08-08',
'order': 0,
'name': 'received',
'label': 'Received',
'group': {'name': 'publication_history', 'label': 'Publication History'}},
{ 'value': '2020-09-08',
'order': 1,
'name': 'accepted',
'label': 'Accepted',
'group': {'name': 'publication_history', 'label': 'Publication History'}},
{ 'value': '2020-10-21',
'order': 2,
'name': 'published',
'label': 'Published',
'group': {'name': 'publication_history', 'label': 'Publication History'}}]}
